These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 26365437)
1. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population. Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437 [TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953 [TBL] [Abstract][Full Text] [Related]
3. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population. Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880 [TBL] [Abstract][Full Text] [Related]
4. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801 [TBL] [Abstract][Full Text] [Related]
5. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation. Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095 [TBL] [Abstract][Full Text] [Related]
6. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population. Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162 [TBL] [Abstract][Full Text] [Related]
7. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population. Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921 [TBL] [Abstract][Full Text] [Related]
8. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation. Chen D; Liu S; Chen S; Wang Z; Wu Z; Ma K; Fan J; Peng Z Int J Clin Oncol; 2016 Dec; 21(6):1111-1119. PubMed ID: 27368337 [TBL] [Abstract][Full Text] [Related]
9. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation. Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726 [TBL] [Abstract][Full Text] [Related]
10. MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis. Tian T; Wang M; Zhu W; Dai ZM; Lin S; Yang PT; Liu XH; Liu K; Zhu YY; Zheng Y; Liu M; Dai ZJ Aging (Albany NY); 2017 Jan; 9(2):381-392. PubMed ID: 28148887 [TBL] [Abstract][Full Text] [Related]
11. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation. Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200 [TBL] [Abstract][Full Text] [Related]
12. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria. Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852 [TBL] [Abstract][Full Text] [Related]
13. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. Wu L; Xu X; Shen J; Xie H; Yu S; Liang T; Wang W; Shen Y; Zhang M; Zheng S J Surg Oncol; 2007 Jul; 96(1):62-8. PubMed ID: 17443726 [TBL] [Abstract][Full Text] [Related]
14. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346 [TBL] [Abstract][Full Text] [Related]
15. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656 [TBL] [Abstract][Full Text] [Related]
16. Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation. Zhang T; Liu Y; Peng X; Fan J; Peng Z Dis Markers; 2017; 2017():1754696. PubMed ID: 29162948 [TBL] [Abstract][Full Text] [Related]
17. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Li XD; Li ZG; Song XX; Liu CF Pathology; 2010 Dec; 42(7):669-73. PubMed ID: 21080878 [TBL] [Abstract][Full Text] [Related]
18. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients. Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375 [TBL] [Abstract][Full Text] [Related]
19. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation. Wu LM; Zhou L; Xu J; Wei BJ; Cheng J; Xu X; Xi B; Xie HY; Zheng SS Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):54-9. PubMed ID: 23392799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]